Brief: Cyclerion Anticipates That Its Current Cash Will Be Sufficient To Fund Its Current CNS Priorities

Korsana Biosciences

05/11/2020 13:00

Nov 5 (Reuters) - Cyclerion Therapeutics Inc  CYCN.O :
    * CYCLERION THERAPEUTICS REPORTS THIRD QUARTER 2020
FINANCIAL
RESULTS AND RECENT CORPORATE UPDATES
    * CYCLERION THERAPEUTICS INC - ANTICIPATES THAT ITS CURRENT
CASH
WILL BE SUFFICIENT TO FUND ITS CURRENT CNS PRIORITIES
    * CYCLERION THERAPEUTICS INC - CASH, CASH EQUIVALENTS, AND
RESTRICTED CASH BALANCE ON SEPTEMBER 30, 2020 WAS APPROXIMATELY
$71 MILLION

Source text for Eikon:  ID:nGNX38JHQr 
Further company coverage:  CYCN.O 

 ((Reuters.Briefs@thomsonreuters.com;))